Gujarat Themis Biosyn share price
You have to be logged in to add this to Watchlist.- ₹385.45(-4.05%)June 10, 2026 15:29:50 PM IST
- NSE
- BSE
- Vol : 124.96 K (NSE + BSE)Last 20 day avg : 327.15 K
Gujarat Themis Biosyn is trading -4.05% lower at Rs 385.45 as compared to its last closing price. Gujarat Themis Biosyn has been trading in the price range of 406.65 & 380.30. Gujarat Themis Biosyn has given -9.17% in this year & 1.56% in the last 5 days. Gujarat Themis Biosyn has TTM P/E ratio 53.01 as compared to the sector P/E of 27.12.The company posted a net profit of 10.89 Crores in its last quarter.Listed peers of Gujarat Themis Biosyn include Cipla (-0.31%), Divi's Laboratories (-1.58%), Sun Pharmaceutical Industries (0.48%).The Mutual Fund holding in Gujarat Themis Biosyn was at 1.16% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Gujarat Themis Biosyn was at 1.80% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jun 10, 2026, 10:00 AM UTC
- Debt To EquityHigher than industry0.56The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.17Annual dividends as a percentage of the stock price.
- P/BHigher than historical values15.22The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values93.91Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-13.43The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Cipla | Neutral | 1,372.55 | -0.31 | 1,10,874.66 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Bullish | 6,649.50 | -1.58 | 1,76,481.54 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Neutral | 1,787.95 | 0.48 | 4,28,713.97 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,453.05 | -0.44 | 1,50,929.78 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Neutral | 1,273.85 | 0.40 | 1,06,317.81 | 18.63 | 3.14 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-06-06 | Fund Raising & Others |
| 2026-05-25 | Audited Results, Dividend & Others |
| 2026-02-05 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE942C01045
- BSE Code506879
- NSE CodeGUJTHEM
Gujarat Themis Biosyn is trading at 385.45 as on Wed Jun 10 2026 09:59:50. This is -4.05% lower as compared to its previous closing price of 401.70.
The market capitalization of Gujarat Themis Biosyn is 4249.79 Cr as on Wed Jun 10 2026 09:59:50.
The 52 wk high for Gujarat Themis Biosyn is 479.45 whereas the 52 wk low is 225.75
Gujarat Themis Biosyn can be analyzed on the following key metrics -
- TTM P/E: 53.01
- Sector P/E: 27.12
- Dividend Yield: 0.17%
- D/E ratio: 0.56
Gujarat Themis Biosyn reported a net profit of 46.68 Cr in 2026.
The Mutual Fund Shareholding was 1.16% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Gujarat Themis Biosyn QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.